• DOI:10.1016/S0140-6736(16)30385-3
Corpus ID: 19728203

Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis

@article{Cipriani2016ComparativeEA,
  title={Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis},
  author={A. Cipriani and X. Zhou and C. Giovane and S. Hetrick and B. Qin and C. Whittington and D. Coghill and Yuqing Zhang and P. Hazell and S. Leucht and P. Cuijpers and Jun-cai Pu and D. Cohen and A. Ravindran and Yiyun Liu and K. Michael and Lining Yang and Lanxiang Liu and P. Xie},
  journal={The Lancet},
  year={2016},
  volume={388},
  pages={881-890}
}

• A. Cipriani, X. Zhou, +16 authors P. Xie
• Published 2016
• Medicine
• The Lancet

BACKGROUND Major depressive disorder is one of the most common mental disorders in children and adolescents. However, whether to use pharmacological interventions in this population and which drug should be preferred are still matters of controversy. Consequently, we aimed to compare and rank antidepressants and placebo for major depressive disorder in young people. METHODS We did a network meta-analysis to identify both direct and indirect evidence from relevant trials. We searched PubMed… Expand